121 related articles for article (PubMed ID: 25138301)
1. Meta-analyses of the effect of CYP1A1 and CYP2D6 polymorphisms on the risk of head and neck squamous cell carcinoma.
Han J; Wang L; Yang Y; Zhang J
Oncol Res Treat; 2014; 37(7-8):406-11. PubMed ID: 25138301
[TBL] [Abstract][Full Text] [Related]
2. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.
Khlifi R; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014; 41(4):2591-600. PubMed ID: 24449363
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
[TBL] [Abstract][Full Text] [Related]
9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Otolaryngol Head Neck Surg; 2003 May; 128(5):674-80. PubMed ID: 12748560
[TBL] [Abstract][Full Text] [Related]
11. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer.
Gattás GJ; de Carvalho MB; Siraque MS; Curioni OA; Kohler P; Eluf-Neto J; Wünsch-Filho V
Head Neck; 2006 Sep; 28(9):819-26. PubMed ID: 16721740
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions.
Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ
Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children.
Aplenc R
Pediatr Blood Cancer; 2004 Oct; 43(5):539-41. PubMed ID: 15382269
[No Abstract] [Full Text] [Related]
17. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
[TBL] [Abstract][Full Text] [Related]
18. [First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
Matthias C; Jahnke V; Fryer AA; Strange RC
Laryngorhinootologie; 2003 Jan; 82(1):25-30. PubMed ID: 12548461
[TBL] [Abstract][Full Text] [Related]
19. Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers.
Liu L; Wu G; Xue F; Li Y; Shi J; Han J; Zhang X; Na Y; Zhang H; Tang X; Pu H; Yuan Q; Zhang L; Yang M
Eur J Cancer; 2013 Jun; 49(9):2143-51. PubMed ID: 23462525
[TBL] [Abstract][Full Text] [Related]
20. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
